184 related articles for article (PubMed ID: 35613689)
21. R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.
Boldes T; Merenbakh-Lamin K; Journo S; Shachar E; Lipson D; Yeheskel A; Pasmanik-Chor M; Rubinek T; Wolf I
BMC Cancer; 2020 Jun; 20(1):531. PubMed ID: 32513126
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced lactate confers ferroptosis resistance via p38-SGK1-NEDD4L-dependent upregulation of GPX4 in NSCLC cells.
Cheng F; Dou J; Yang Y; Sun S; Chen R; Zhang Z; Wei H; Li J; Wu Z
Cell Death Discov; 2023 May; 9(1):165. PubMed ID: 37188685
[TBL] [Abstract][Full Text] [Related]
23. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
24. SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells.
Yang H; Yu N; Xu J; Ding X; Deng W; Wu G; Li X; Hou Y; Liu Z; Zhao Y; Xue M; Yu S; Wang B; Li X; Niu G; Wang H; Zhu J; Zhuang T
J Exp Clin Cancer Res; 2018 Feb; 37(1):24. PubMed ID: 29433542
[TBL] [Abstract][Full Text] [Related]
25. p53 Binds to estrogen receptor 1 promoter in human breast cancer cells.
Rasti M; Arabsolghar R; Khatooni Z; Mostafavi-Pour Z
Pathol Oncol Res; 2012 Apr; 18(2):169-75. PubMed ID: 21655924
[TBL] [Abstract][Full Text] [Related]
26. Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer.
Guo Y; Cui Y; Li Y; Jin X; Wang D; Lei M; Chen F; Liu Y; Xu J; Yao G; Zeng G; Chen X
Cancer Commun (Lond); 2023 May; 43(5):582-612. PubMed ID: 37005481
[TBL] [Abstract][Full Text] [Related]
27. The ESR1 and GPX1 gene expression level in human malignant and non-malignant breast tissues.
Król MB; Galicki M; Grešner P; Wieczorek E; Jabłońska E; Reszka E; Morawiec Z; Wąsowicz W; Gromadzińska J
Acta Biochim Pol; 2018; 65(1):51-57. PubMed ID: 29543921
[TBL] [Abstract][Full Text] [Related]
28. Deletion of ubiquitin ligase Nedd4l exacerbates ischemic brain damage.
Kim T; Chokkalla AK; Vemuganti R
J Cereb Blood Flow Metab; 2021 May; 41(5):1058-1066. PubMed ID: 32703111
[TBL] [Abstract][Full Text] [Related]
29. NEDD4L mediates ITGB4 ubiquitination and degradation to suppress esophageal carcinoma progression.
Shi Y; Fang N; Wu Y; Xu H; Ning A; Zhang W; Liu Y; Tao X; Chen Q; Tian T; Zhang L; Chu M; Cui J
Cell Commun Signal; 2024 Jun; 22(1):302. PubMed ID: 38831335
[TBL] [Abstract][Full Text] [Related]
30. Ionizing radiation downregulates estradiol synthesis via endoplasmic reticulum stress and inhibits the proliferation of estrogen receptor-positive breast cancer cells.
Yang P; Feng X; Li J; Zhang T; Sheng C; Zhang L; Hua J; Wei W; Ding N; He J; Zhang Y; Wang J; Zhou H
Cell Death Dis; 2021 Oct; 12(11):1029. PubMed ID: 34716300
[TBL] [Abstract][Full Text] [Related]
31. The E3 ubiquitin ligase, NEDD4L (NEDD4-2) regulates bestrophin-1 (BEST1) by ubiquitin-dependent proteolysis.
Park M; Jung HG; Kweon HJ; Kim YE; Park JY; Hwang EM
Biochem Biophys Res Commun; 2019 Jun; 514(1):344-350. PubMed ID: 31036321
[TBL] [Abstract][Full Text] [Related]
32. Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
Carlisle SM; Hein DW
Int J Oncol; 2018 Aug; 53(2):694-702. PubMed ID: 29901116
[TBL] [Abstract][Full Text] [Related]
33. PSF Promotes ER-Positive Breast Cancer Progression via Posttranscriptional Regulation of
Mitobe Y; Iino K; Takayama KI; Ikeda K; Suzuki T; Aogi K; Kawabata H; Suzuki Y; Horie-Inoue K; Inoue S
Cancer Res; 2020 Jun; 80(11):2230-2242. PubMed ID: 32213542
[TBL] [Abstract][Full Text] [Related]
34. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
[TBL] [Abstract][Full Text] [Related]
35. ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling.
Gelsomino L; Gu G; Rechoum Y; Beyer AR; Pejerrey SM; Tsimelzon A; Wang T; Huffman K; Ludlow A; Andò S; Fuqua SAW
Breast Cancer Res Treat; 2016 Jun; 157(2):253-265. PubMed ID: 27178332
[TBL] [Abstract][Full Text] [Related]
36. NEDD4L limits cAMP signaling through ubiquitination of CREB-regulated transcription coactivator 3.
Kim YH; Yoo H; Hong AR; Kwon M; Kang SW; Kim K; Song Y
FASEB J; 2018 Jul; 32(7):4053-4062. PubMed ID: 29505301
[TBL] [Abstract][Full Text] [Related]
37. DNA Damage Response After Ionizing Radiation Exposure in Skin Keratinocytes Derived from Human-Induced Pluripotent Stem Cells.
Miyake T; Shimada M; Matsumoto Y; Okino A
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):193-205. PubMed ID: 31085283
[TBL] [Abstract][Full Text] [Related]
38. Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR.
Maekawa R; Sato S; Okada M; Lee L; Tamura I; Jozaki K; Kajimura T; Asada H; Yamagata Y; Tamura H; Yamamoto S; Sugino N
Mol Endocrinol; 2016 Mar; 30(3):335-47. PubMed ID: 26683811
[TBL] [Abstract][Full Text] [Related]
39. Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy.
Liu W; Ip MM; Podgorsak MB; Das GM
Breast Cancer Res Treat; 2009 May; 115(1):43-50. PubMed ID: 18481172
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
